Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-09-28
1990-07-10
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514411, 548253, 548439, A61K 31395, A61K 3141, C07D20982, C07D40302
Patent
active
049407198
ABSTRACT:
Tetrahydrocarbazole esters are disclosed. The compounds act as prostaglandin and thromboxane antagonists and are useful in treating asthma, diarrhea, hypertension, angina, platelet aggregation, cerebral spasm, premature labor, spontaneous abortion and dysmenorrhea and nephrotoxicity caused by cyclosporin A and as cytoprotective agents.
REFERENCES:
patent: 3896145 (1975-07-01), Berger et al.
patent: 4009181 (1977-02-01), Berger et al.
patent: 4057559 (1977-11-01), Asselin et al.
patent: 4808608 (1989-02-01), Guindon et al.
Shen et al, The Development of Antiasthmatic Drugs III, Butterworth Publisher, Kent, Engl 1981 pp. 315-317 and 331-335.
Gillard John W.
Girard Yves
Guindon Yvan
Yoakim Christiane
Caruso Charles M.
Lopez Gabriel
Merck Frosst Canada Inc.
Pfeiffer Hesna J.
Ramsuer Robert W.
LandOfFree
Tetrahydrocarbazole esters, pharmaceutical compositions and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrocarbazole esters, pharmaceutical compositions and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrocarbazole esters, pharmaceutical compositions and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1721145